Evaluation of regulated delayed attenuation strategies for Salmonella enterica serovar typhi vaccine vectors in neonatal and infant mice

Clinical and Vaccine Immunology

Volumn 20, Issue 6, 2013, Pages 867-876

  Shi, Huoying ^a,b   Wang, Shifeng ^a   Curtiss III, Roy ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VECTOR; BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; PNEUMOCOCCUS VACCINE; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; DRUG CARRIER; LIVE VACCINE; PNEUMOCOCCAL SURFACE PROTEIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION RESISTANCE; LYMPHOID TISSUE; MALE; MICROBIAL ATTENUATION; MOUSE; NEWBORN; NONHUMAN; NOSE LYMPHOID TISSUE; PEYER PATCH; PHENOTYPE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; SALMONELLA ENTERICA; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; VAGINA MUCOSA; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; DISEASE MODEL; GENETICS; IMMUNOLOGY; LUNG; MICROBIOLOGY; NOSE CAVITY; PNEUMOCOCCAL INFECTIONS; PROCEDURES; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; VACCINATION; VAGINA;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL LOAD; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-4; LUNG; MICE; MICE, INBRED BALB C; NASAL CAVITY; PEYER'S PATCHES; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SALMONELLA TYPHI; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, ATTENUATED; VAGINA;

EID: 84891428736     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00003-13     Document Type: Article

References (60)

1. Adkins B, Leclerc C, Marshall-Clarke S. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4:553-564. (Pubitemid 38931770)
2. Crowe JE, Jr. 2001. Influence of maternal antibodies on neonatal immunization against respiratory viruses. Clin. Infect. Dis. 33:1720-1727. (Pubitemid 33044540)
3. Levy O. 2007. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7:379-390. (Pubitemid 46674489)
4. Siegrist CA. 2007. The challenges of vaccine responses in early life: selected examples. J. Comp. Pathol. 137(Suppl 1):S4-S9.
5. Moon JJ, McSorley SJ. 2009. Tracking the dynamics of Salmonella specific T cell responses. Curr. Top. Microbiol. Immunol. 334:179-198.
6. Srinivasan A, McSorley SJ. 2006. Activation of Salmonella-specific immune responses in the intestinal mucosa. Arch. Immunol. Ther. Exp. (Warsz.) 54:25-31. (Pubitemid 44124219)
7. Griffin AJ, McSorley SJ. 2011. Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda. Mucosal Immunol. 4:371-382.
8. Broz P, Ohlson MB, Monack DM. 2012. Innate immune response to Salmonella typhimurium, a model enteric pathogen. Gut Microbes 3:62-70.
9. Tam MA, Rydstrom A, Sundquist M, Wick MJ. 2008. Early cellular responses to Salmonella infection: dendritic cells, monocytes, and more. Immunol. Rev. 225:140-162.
10. Galen JE, Pasetti MF, Tennant S, Ruiz-Olvera P, Sztein MB, Levine MM. 2009. Salmonella enterica serovar Typhi live vector vaccines finally come of age. Immunol. Cell Biol. 87:400-412.
11. Hohmann EL, Oletta CA, Miller SI. 1996. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine 14:19-24. (Pubitemid 26046542)
12. Curtiss R, III, Wanda SY, Gunn BM, Zhang X, Tinge SA, Ananthnarayan V, Mo H, Wang S, Kong W. 2009. Salmonella enterica serovar Typhimurium strains with regulated delayed attenuation in vivo. Infect. Immun. 77:1071-1082.
13. Shi H, Wang S, Roland KL, Gunn BM, Curtiss R, III. 2010. Immunogenicity of a live recombinant Salmonella enterica serovar Typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers. Clin. Vaccine Immunol. 17:363-371.
14. Li Y, Wang S, Scarpellini G, Gunn B, Xin W, Wanda SY, Roland KL, Curtiss R, III. 2009. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc. Natl. Acad. Sci. U. S. A. 106:593-598.
15. Shi H, Santander J, Brenneman KE, Wanda SY, Wang S, Senechal P, Sun W, Roland KL, Curtiss R, III. 2010. Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen. PLoS One 5:e11142. doi:10.1371/journal.pone.0011142.
16. Curtiss R, III, Zhang X, Wanda SY, Kang HY, Konjufca V, Li Y, Gunn B, Wang S, Scarpellini G, Lee IS. 2007. Induction of host immune responses using Salmonella-vectored vaccines. In Brogden KA, Minion FC, Cornick N, Stanton TB, Zhang Q, Nolan LK, Wannemuehler MJ (ed), Virulence mechanisms of bacterial pathogens, 4th ed. ASM Press, Washington DC.
17. Gunn BM, Wanda SY, Burshell D, Wang C, Curtiss R, III. 2010. Construction of recombinant attenuated Salmonella enterica serovar Typhimurium vaccine vector strains for safety in newborn and infant mice. Clin. Vaccine Immunol. 17:354-362.
18. Santander J, Wanda SY, Nickerson CA, Curtiss R, III. 2007. Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi. Infect. Immun. 75:1382-1392. (Pubitemid 46385832)
19. Briles DE, King JD, Gray MA, McDaniel LS, Swiatlo E, Benton KA. 1996. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 14:858-867. (Pubitemid 26280926)
20. Kang HY, Srinivasan J, Curtiss R, III. 2002. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect. Immun. 70:1739-1749. (Pubitemid 34242173)
21. Xin W, Wanda SY, Li Y, Wang S, Mo H, Curtiss R, III. 2008. Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect. Immun. 76:3241-3254.
22. Germanier R, Furer E. 1975. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J. Infect. Dis. 131:553-558.
23. Bertani G. 1951. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J. Bacteriol. 62:293-300.
24. Kusters JG, Mulders-Kremers GA, van Doornik CE, van der Zeijst BA. 1993. Effects of multiplicity of infection, bacterial protein synthesis, and growth phase on adhesion to and invasion of human cell lines by Salmonella typhimurium. Infect. Immun. 61:5013-5020. (Pubitemid 23353874)
25. Watson PR, Paulin SM, Bland AP, Jones PW, Wallis TS. 1995. Characterization of intestinal invasion by Salmonella typhimurium and Salmonella dublin and effect of a mutation in the invH gene. Infect. Immun. 63:2743-2754.
26. Valle E, Guiney DG. 2005. Characterization of Salmonella-induced cell death in human macrophage-like THP-1 cells. Infect. Immun. 73:2835-2840. (Pubitemid 40570351)
27. Nickerson CA, Curtiss R, III. 1997. Role of sigma factor RpoS in initial stages of Salmonella typhimurium infection. Infect. Immun. 65:1814-1823. (Pubitemid 27193605)
28. Pickett TE, Pasetti MF, Galen JE, Sztein MB, Levine MM. 2000. In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors. Infect. Immun. 68:205-213. (Pubitemid 30016698)
29. Nayak AR, Tinge SA, Tart RC, McDaniel LS, Briles DE, Curtiss R, III. 1998. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae. Infect. Immun. 66:3744-3751. (Pubitemid 28347832)
30. Rosen SM, Zeleznick LD, Fraenkel D, Wiener IM, Osborn MJ, Horecker BL. 1965. Characterization of the cell wall lipopolysaccharide of a mutant of Salmonella typhimurium lacking phosphomannose isomerase. Biochem. Z. 342:375-386.
31. Galyov EE, Wood MW, Rosqvist R, Mullan PB, Watson PR, Hedges S, Wallis TS. 1997. A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and mediates inflammation and fluid secretion in infected ileal mucosa. Mol. Microbiol. 25:903-912. (Pubitemid 27397519)
32. Santos RL, Tsolis RM, Zhang S, Ficht TA, Baumler AJ, Adams LG. 2001. Salmonella-induced cell death is not required for enteritis in calves. Infect. Immun. 69:4610-4617. (Pubitemid 32574462)
33. Li Y, Wang S, Xin W, Scarpellini G, Shi Z, Gunn B, Roland KL, Curtiss R, III. 2008. A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines. Infect. Immun. 76:5238-5246.
34. Wang S, Li Y, Shi H, Sun W, Roland KL, Curtiss R, III. 2011. Comparison of a regulated delayed antigen synthesis system with in vivoinducible promoters for antigen delivery by live attenuated Salmonella vaccines. Infect. Immun. 79:937-949.
35. Bollen WS, Gunn BM, Mo H, Lay MK, Curtiss R, III. 2008. Presence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routes. Infect. Immun. 76:3268-3272.
36. Wang S, Li Y, Shi H, Scarpellini G, Torres-Escobar A, Roland KL, Curtiss R, III. 2010. Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine. Infect. Immun. 78:3258-3271.
37. Giannella RA, Washington O, Gemski P, Formal SB. 1973. Invasion of HeLa cells by Salmonella typhimurium: a model for study of invasiveness of Salmonella. J. Infect. Dis. 128:69-75.
38. Bovallius A, Nilsson G. 1975. Ingestion and survival of Y. pseudotuberculosis in HeLa cells. Can. J. Microbiol. 21:1997-2007.
39. Jones GW, Richardson LA. 1981. The attachment to, and invasion of HeLa cells by Salmonella typhimurium: the contribution of mannosesensitive and mannose-resistant haemagglutinating activities. J. Gen. Microbiol. 127:361-370. (Pubitemid 12139389)
40. Small PL, Isberg RR, Falkow S. 1987. Comparison of the ability of enteroinvasive Escherichia coli, Salmonella typhimurium, Yersinia pseudotuberculosis, and Yersinia enterocolitica to enter and replicate within HEp-2 cells. Infect. Immun. 55:1674-1679. (Pubitemid 17084162)
41. Vesikari T, Bromirska J, Maki M. 1982. Enhancement of invasiveness of Yersinia enterocolitica and Escherichia coli in HEp-2 cells by centrifugation. Infect. Immun. 36:834-836. (Pubitemid 12101917)
42. Mills SD, Finlay BB. 1994. Comparison of Salmonella typhi and Salmonella typhimurium invasion, intracellular growth and localization in cultured human epithelial cells. Microb. Pathog. 17:409-423.
43. Bishop A, House D, Perkins T, Baker S, Kingsley RA, Dougan G. 2008. Interaction of Salmonella enterica serovar Typhi with cultured epithelial cells: roles of surface structures in adhesion and invasion. Microbiology 154:1914-1926.
44. Sizemore DR, Elsinghorst EA, Eck LC, Branstrom AA, Hoover DL, Warren RL, Rubin FA. 1997. Interaction of Salmonella typhi strains with cultured human monocyte-derived macrophages. Infect. Immun. 65:309-312. (Pubitemid 27008939)
45. Pasetti MF, Levine MM, Sztein MB. 2003. Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors. Vaccine 21:401-418. (Pubitemid 36091930)
46. Galen JE, Gomez-Duarte OG, Losonsky GA, Halpern JL, Lauderbaugh CS, Kaintuck S, Reymann MK, Levine MM. 1997. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. Vaccine 15:700-708. (Pubitemid 27240486)
47. Siegrist CA. 2001. Neonatal and early life vaccinology. Vaccine 19:3331-3346.
48. Burget EG, Verma R, Molhoj M, Reiter WD. 2003. The biosynthesis of L-arabinose in plants: molecular cloning and characterization of a Golgi-localized UDP-D-xylose 4-epimerase encoded by the MUR4 gene of Arabidopsis. Plant Cell 15:523-531. (Pubitemid 36230002)
49. Krog-Mikkelsen I, Hels O, Tetens I, Holst JJ, Andersen JR, Bukhave K. 2011. The effects of L-arabinose on intestinal sucrase activity: dose-response studies in vitro and in humans. Am. J. Clin. Nutr. 94:472-478.
50. Huck JH, Verhoeven NM, Struys EA, Salomons GS, Jakobs C, van der Knaap MS. 2004. Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy. Am. J. Hum. Genet. 74:745-751. (Pubitemid 38420104)
51. Kong W, Wanda SY, Zhang X, Bollen W, Tinge SA, Roland KL, Curtiss R, III. 2008. Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. Proc. Natl. Acad. Sci. U. S. A. 105:9361-9366.
52. Monsma DJ, Marlett JA. 1996. Fermentation of carbohydrate in rat ileal excreta is enhanced with cecal inocula compared with fecal inocula. J. Nutr. 126:554-563. (Pubitemid 26055788)
53. Lobley RW, Burrows PC, Warwick R, Dawson DJ, Holmes R. 1990. Simultaneous assessment of intestinal permeability and lactose tolerance with orally administered raffinose, lactose and L-arabinose. Clin. Sci. (Lond.) 79:175-183. (Pubitemid 20218958)
54. Wang S, Li Y, Scarpellini G, Kong W, Shi H, Baek CH, Gunn B, Wanda SY, Roland KL, Zhang X, Senechal-Willis P, Curtiss R, III. 2010. Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity. Infect. Immun. 78:3969-3980.
55. Sun W, Roland KL, Kuang X, Branger CG, Curtiss R, III. 2010. Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague. Infect. Immun. 78:1304-1313.
56. Territo MC, Cline MJ. 1977. Monocyte function in man. J. Immunol. 118:187-192. (Pubitemid 8028920)
57. Tacket CO, Sztein MB, Losonsky GA, Wasserman SS, Nataro JP, Edelman R, Pickard D, Dougan G, Chatfield SN, Levine MM. 1997. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect. Immun. 65:452-456. (Pubitemid 27053208)
58. Hone DM, Harris AM, Chatfield S, Dougan G, Levine MM. 1991. Construction of genetically defined double aro mutants of Salmonella typhi. Vaccine 9:810-816.
59. Felix A, Pitt RM. 1951. The pathogenic and immunogenic activities of Salmonella typhi in relation to its antigenic constituents. J. Hyg. (Lond.) 49:92-110.
60. Curtiss R, III, Porter SB, Munson M, Tinge SA, Hassan JO, Gentry-Weeks C, Kelly SM. 1991. Nonrecombinant and recombinant avirulent Salmonella live vaccines for poultry, p 169-198. In Blankenship LC, Bailey JS, Cox NA, Craven SE, Meinersmann RJ, Stern NJ (ed), Colonization control of human bacterial enteropathogens in poultry. Academic Press, New York, NY.